Litigation Details for Shire Development LLC v. InvaGen Pharmaceuticals, Inc. (E.D.N.Y 2014)
✉ Email this page to a colleague
Shire Development LLC v. InvaGen Pharmaceuticals, Inc. (E.D.N.Y 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-12-11 |
| Court | District Court, E.D. New York | Date Terminated | 2015-01-15 |
| Cause | 35:271 Patent Infringement | Assigned To | Brian Mark Cogan |
| Jury Demand | None | Referred To | |
| Patents | 7,381,428; 7,465,465 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Shire Development LLC v. InvaGen Pharmaceuticals, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Shire Development LLC v. InvaGen Pharmaceuticals, Inc. (E.D.N.Y 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-12-11 | 1 | United States Patent Nos. 5,968,976 (“the ’976 patent”), 7,381,428 (“the ’428 patent”), and 7,465,465… ’976 patent; claims 2-3 or 8-9 of the ’428 patent; or claims 5- 8 or 11-12 of the ’465 patent. … This is a civil action for patent infringement arising under the patent laws of the United States, …title, and interest in the ’976 patent. 13. The ’428 patent, entitled “Stabilized Lanthanum…title, and interest in the ’428 patent. 14. The ’465 patent, entitled “Pharmaceutical Formulation | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
